Dr. Finanger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 Sw Sam Jackson Park Rd
Cdrc-P
Portland, OR 97239Phone+1 503-494-5856Fax+1 503-494-2370
Education & Training
- Johns Hopkins UniversityFellowship, Neuromuscular Medicine (Neurology), 2008 - 2009
- Johns Hopkins UniversityFellowship, Child Neurology, 2005 - 2008
- Mayo Clinic College of MedicineClass of 2003
Certifications & Licensure
- OR State Medical License 2009 - 2025
- WA State Medical License 2023 - 2025
- MD State Medical License 2008 - 2010
- MN State Medical License 2004 - 2005
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Clinical Trials
- A Study of Tadalafil for Duchenne Muscular Dystrophy Start of enrollment: 2013 Sep 01
- A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy Start of enrollment: 2014 Aug 19
- Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy Start of enrollment: 2015 Jun 30
Publications & Presentations
PubMed
- 254 citationsNatural history of infantile-onset spinal muscular atrophy.Stephen J. Kolb, Christopher S. Coffey, Jon W. Yankey, Kristin J. Krosschell, W. David Arnold
Annals of Neurology. 2017-12-01 - 2 citationsBiallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.Lauren Jeffries, Emily K Mis, Kirsty McWalter, Sandra Donkervoort, Nina N Brodsky
Genetics in Medicine. 2024-02-01 - 95 citationsBaseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study.Stephen J. Kolb, Christopher S. Coffey, Jon W. Yankey, Kristin J. Krosschell, W. David Arnold
Annals of Clinical and Translational Neurology. 2016-02-01
Press Mentions
- Local Girl Receives First at-Home Treatment for Rare DiseaseNovember 13th, 2020
- Catabasis Pharmaceuticals Reports First Quarter 2020 Financial Results and Reviews Business ProgressMay 12th, 2020
- Edasalonexent May Limit Disease Progression in Boys with Duchenne MD, Phase 1/2 Trial ShowsMarch 1st, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: